drugset / Trial / NCT06443632

WASPE Sleep Adjustment for Children Aged 0-4 Years Undergoing Radiation Therapy

NCT06443632

RandomizedParallel-groupOpen-labelSupportive care

Summary

This prospective, randomized controlled feasibility trial aims to evaluate the feasibility and effectiveness of a behavioral sleep adjustment protocol (WASPE: Watching videos, Activities outdoors, Stimulation to stay awake, Playing with toys, Eating snacks) in pediatric patients undergoing radiotherapy. A total of 48 children aged 0-4 years with non-head-and-neck tumors were enrolled and allocated to either the WASPE sleep adjustment group or the sedation group. The primary outcome was the rate of radiotherapy completion without sedation in the WASPE group. Secondary outcomes included motion accuracy (CBCT and OSMS) and physiological biomarkers (IgA, IgG, IgM, GH). This study explores a non-pharmacological alternative to sedation in pediatric radiotherapy preparation.

Timeline

Start
2024-06-01
Primary completion
2025-06-01
Completion
2025-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chloral Hydrate Small molecule 30 mg/kg Oral
Comparator Chloral Hydrate Small molecule 50 mg/kg Oral